On March 1, 2024, Voyageur Pharmaceuticals Ltd. closed the transaction. The company announced that it has issued 6,106,250 Units at an issue price of CAD 0.08 per unit for the gross proceeds of CAD 488,500. Each unit shall be comprised of one common share and one common share purchase warrant, each warrant exercisable at cad 0.15 for twenty-four months from closing. In connection with the Offering, Voyageur paid cash commissions to qualified non-related parties of CAD 10,440 and issued an aggregate of 130,500 broker warrants. Each Broker Warrant entitles the holder to acquire one Common Share at a price of CAD 0.08 per Broker Warrant for a period of one year from the date of issuance.

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement. The transaction included participation from 22 placees.